Aggelos Stefos

An open label trial of anakinra to prevent respiratory failure in COVID-19

Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis et al. · eLife · 2021 · 192 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Ceftazidime/avibactam in the era of carbapenemase-producing <i>Klebsiella pneumoniae</i>: experience from a national registry study

Ilias Karaiskos, George L. Daikos, Aikaterini Gkoufa et al. · Journal of Antimicrobial Chemotherapy · 2020 · 101 citations

Veterinary Medicine, Infectious Diseases, Microbiology +9

Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

Lea Papst, Bojana Beović, C. Pulcini et al. · Clinical Microbiology and Infection · 2018 · 88 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome

E. Kapsalaki, Nikolaos Gatselis, Aggelos Stefos et al. · International Journal of Infectious Diseases · 2008 · 82 citations · Full text

Medicine, Infectious Diseases, Orthopaedic Surgery +13

Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection

Dimitrios Sinapidis, Vassileios Kosmas, Vasileios Vittoros et al. · BMC Infectious Diseases · 2018 · 81 citations · Full text

Veterinary Medicine, Infectious Diseases, Host-pathogen Interactions +14